tiprankstipranks
Trans Genic Inc. (JP:2342)
:2342
Japanese Market
Want to see JP:2342 full AI Analyst Report?

Trans Genic Inc. (2342) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Trans Genic Inc. has a market cap or net worth of ¥3.54B. The enterprise value is ¥4.05B.
Market Cap¥3.54B
Enterprise Value¥4.05B

Share Statistics

Trans Genic Inc. has 16,999,142 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,999,142
Owned by Insiders
Owned by Institutions

Financial Efficiency

Trans Genic Inc.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 0.92%.
Return on Equity (ROE)-0.02
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)0.92%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee55.82M
Profits Per Employee-327.41K
Employee Count236
Asset Turnover1.35
Inventory Turnover4.34

Valuation Ratios

The current PE Ratio of Trans Genic Inc. is ―. Trans Genic Inc.’s PEG ratio is 0.59.
PE Ratio
PS Ratio0.32
PB Ratio0.89
Price to Fair Value0.89
Price to FCF-100.19
Price to Operating Cash Flow0.00
PEG Ratio0.59

Income Statement

In the last 12 months, Trans Genic Inc. had revenue of 13.17B and earned -77.27M in profits. Earnings per share was -4.64.
Revenue13.17B
Gross Profit2.43B
Operating Income137.96M
Pretax Income-207.44M
Net Income-77.27M
EBITDA293.56M
Earnings Per Share (EPS)-4.64

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Trans Genic Inc. pays an annual dividend of ¥3, resulting in a dividend yield of ―
Dividend Per Share¥3
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.05
52-Week Price Change36.36%
50-Day Moving Average257.00
200-Day Moving Average257.29
Relative Strength Index (RSI)30.55
Average Volume (3m)549.15K

Important Dates

Trans Genic Inc. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date

Financial Position

Trans Genic Inc. as a current ratio of 1.74, with Debt / Equity ratio of 43.70%
Current Ratio1.74
Quick Ratio1.10
Debt to Market Cap0.49
Net Debt to EBITDA-0.16
Interest Coverage Ratio3.01

Taxes

In the past 12 months, Trans Genic Inc. has paid -109.98M in taxes.
Income Tax-109.98M
Effective Tax Rate0.53

Enterprise Valuation

Trans Genic Inc. EV to EBITDA ratio is 14.37, with an EV/FCF ratio of -99.11.
EV to Sales0.32
EV to EBITDA14.37
EV to Free Cash Flow-99.11
EV to Operating Cash Flow162.76

Balance Sheet

Trans Genic Inc. has ¥2.30B in cash and marketable securities with ¥2.85B in debt, giving a net cash position of -¥546.05M billion.
Cash & Marketable Securities¥2.30B
Total Debt¥2.85B
Net Cash-¥546.05M
Net Cash Per Share-¥32.12
Tangible Book Value Per Share¥260.24

Margins

Gross margin is 18.47%, with operating margin of 1.05%, and net profit margin of -0.59%.
Gross Margin18.47%
Operating Margin1.05%
Pretax Margin-1.57%
Net Profit Margin-0.59%
EBITDA Margin2.23%
EBIT Margin1.05%

Analyst Forecast

The average price target for Trans Genic Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast1.30%
EPS Growth Forecast92.91%

Scores

Smart ScoreN/A
AI Score